BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23427287)

  • 1. Effect of vascular endothelial growth factor receptor 2 antagonism on adiposity in obese mice.
    Lijnen HR; Scroyen I
    J Mol Endocrinol; 2013 Jun; 50(3):319-24. PubMed ID: 23427287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of angiogenesis during adipose tissue development in murine models of obesity.
    Voros G; Maquoi E; Demeulemeester D; Clerx N; Collen D; Lijnen HR
    Endocrinology; 2005 Oct; 146(10):4545-54. PubMed ID: 16020476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts.
    Davis DW; Inoue K; Dinney CP; Hicklin DJ; Abbruzzese JL; McConkey DJ
    Cancer Res; 2004 Jul; 64(13):4601-10. PubMed ID: 15231672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
    Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP
    Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gelatinase inhibition on adipogenesis and adipose tissue development.
    Van Hul M; Bauters D; Himmelreich U; Kindt N; Noppen B; Vanhove M; Lijnen HR
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):49-56. PubMed ID: 22026722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity.
    Lijnen HR; Frederix L; Van Hoef B
    Obesity (Silver Spring); 2010 Dec; 18(12):2241-6. PubMed ID: 20094042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of vascular endothelial growth factor-D does not affect murine adipose tissue development.
    Lijnen HR; Frederix L; Van Hoef B; Dewerchin M
    Biochem Biophys Res Commun; 2009 Jan; 378(2):255-8. PubMed ID: 19022221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
    Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity.
    Lijnen HR; Maquoi E; Demeulemeester D; Van Hoef B; Collen D
    Thromb Haemost; 2002 Aug; 88(2):345-53. PubMed ID: 12195710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of thrombospondin-2 in murine adipose tissue angiogenesis and development.
    Van Hul M; Frederix L; Lijnen HR
    Obesity (Silver Spring); 2012 Sep; 20(9):1757-62. PubMed ID: 21818150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiplaxtinin impairs nutritionally induced obesity in mice.
    Lijnen HR; Alessi MC; Frederix L; Collen D; Juhan-Vague I
    Thromb Haemost; 2006 Dec; 96(6):731-7. PubMed ID: 17139366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
    Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromelysin-2 (MMP-10) deficiency does not affect adipose tissue formation in a mouse model of nutritionally induced obesity.
    Lijnen HR; Van Hoef B; Rodriguez JA; Paramo JA
    Biochem Biophys Res Commun; 2009 Nov; 389(2):378-81. PubMed ID: 19732744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
    Camp ER; Yang A; Liu W; Fan F; Somcio R; Hicklin DJ; Ellis LM
    Clin Cancer Res; 2006 Apr; 12(8):2628-33. PubMed ID: 16638876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Wu Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Tsujinoue H; Masaki T; Fukui H
    Hepatology; 2004 Jun; 39(6):1517-24. PubMed ID: 15185292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vascular endothelial growth factor receptor tyrosine kinases impairs adipose tissue development in mouse models of obesity.
    Lijnen HR; Van Hoef B; Kemp D; Collen D
    Biochim Biophys Acta; 2007 Sep; 1770(9):1369-73. PubMed ID: 17616257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.